EXP vs SRPT · P/E 16, rev $2.26B vs rev $1.90B
Eagle Materials Inc (EXP) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Eagle Materials Inc (EXP) is a building materials company listed on NYSE.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported EXP revenue for 2025-03-31 was $2.26B. Net income was $463.4M. Revenue was up 0.1% from 2024-03-31 to 2025-03-31. EXP currently screens at market cap $6.59B and trailing P/E 16.2.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
EXP currently screens at market cap $6.59B and trailing P/E 16.2. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the EXP and SRPT stock pages for the full models.
Not investment advice.